Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model

por Takeshita, H, Kusuzaki, K, Murata, H, Suginoshita, T, Hirata, M, Hashiguchi, S, Ashihara, T, Gebhardt, M C, Mankin, H J, Hirasawa, Y
Publicado 2000

Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study

por Sims, KB, Pastores, GM, Weinreb, NJ, Barranger, J, Rosenbloom, BE, Packman, S, Kaplan, P, Mankin, H, Xavier, R, Angell, J, Fitzpatrick, MA, Rosenthal, D
Publicado 2008

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925

por Yang, X, Yang, P, Shen, J, Osaka, E, Choy, E, Cote, G, Harmon, D, Zhang, Z, Mankin, H, Hornicek, F J, Duan, Z
Publicado 2014